Shuxin Yin, PhD

Soleno Therapeutics, Inc.
Redwood City, California, United States

Disclosure information not submitted.

Presentation(s):

• SUN-689 - Efficacy and Safety of Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal in Prader-Willi Syndrome (PWS) (Study C614)

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT